Conrad Liles
W. Conrad Liles, MD, PhD is a Principal Investigator at at Sandra A. Rotman Laboratories, McLaughlin Rotman Centre for Global Health within the Translational Research Pillar.
Dr. Liles is Professor and Vice-Chair of Medicine and Director of the Division of Infectious Diseases at the University of Toronto. He graduated magna cum laude from Williams College (USA), then entered the National Institutes of Health (NIH)-sponsored MD-PhD program (Medical Scientist Training Program) at the University of Washington (USA) and graduated in 1987 with an MD and a PhD in pharmacology. Following residency in Internal Medicine at Massachusetts General Hospital from 1987-1990, he returned to the University of Washington where he served as Chief Medical Resident in 1991 and as a Fellow in Infectious Diseases from 1992-1995. In 1996, he was appointed to the faculty at the University of Washington as Assistant Professor of Medicine in the Division of Allergy and Infectious Diseases and rose to the rank of Professor of Medicine and Adjunct Professor of Pathology. In March 2006, Dr. Liles moved to the University of Toronto to assume his current positions. He was attracted to the University of Toronto by the opportunities to build translational research programs in sepsis, emerging infectious diseases and infectious diseases of public health importance, including malaria. He is the recipient of a Canada Research Chair (Tier 1) in Inflammation and Infectious Diseases and a member of the McLaughlin Centre for Molecular Medicine, the McLaughlin-Rotman Centre for Global Health, and the Toronto General Research Institute.
As author of more than 150 peer-reviewed manuscripts and 35 book chapters, Dr. Liles maintains an active translational research program as a principal investigator in host defense, inflammation, innate immunity, sepsis, immunodeficiency disorders, and immunomodulatory therapy, while serving as a chartered member of the Immunity and Host Defense Study Section of the NIH. In 2004, Dr. Liles received the Outstanding Investigator Award from the Western Society for Clinical Investigation (WSCI). He has been elected to Fellowship in the American College of Physicians (ACP) and the Infectious Diseases Society of America (IDSA). He also served as Acting Chair of Medicine at the University of Toronto during the fall of 2009.

